Cloning and characterization of the promoter region of human focal adhesion kinase gene: nuclear factor kappa B and p53 binding sites-Reference-Cited by-同舟云学术

Cloning and characterization of the promoter region of human focal adhesion kinase gene: nuclear factor kappa B and p53 binding sites

Published:2004-05 Issue:2-3 Volume:1678 Page:111-125
ISSN:0167-4781
Container-title:Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression
language:en
Short-container-title:Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression

Author:

Golubovskaya Vita,Kaur Aparna,Cance William

Funder

National Cancer Institute

Publisher

Elsevier BV

Subject

Genetics,Biochemistry,Biophysics,Structural Biology

Reference48 articles.

1. Signaling through focal adhesion kinase;Hanks;BioEssays,1997

2. Focal adhesion kinase;Zachary;Int. J. Biochem. Cell Biol.,1997

3. Inhibition of focal adhesion kinase expression or activity disrupts epidermal growth factor-stimulated signaling promoting the migration of invasive human carcinoma cells;Hauck;Cancer Res.,2001

4. The focal adhesion kinase suppresses transformation-associated, anchorage-Independent apoptosis in human breast cancer cells;Xu;J. Biol. Chem.,2000

5. Dual inhibition of focal adhesion kinase and epidermal growth factor receptor pathways cooperatively induces death receptor-mediated apoptosis in human breast cancer cells;Golubovskaya;J. Biol. Chem.,2002

Cited by 133 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. FAK in Cancer: From Mechanisms to Therapeutic Strategies;International Journal of Molecular Sciences;2022-02-02

2. G9a Promotes Invasion and Metastasis of Non–Small Cell Lung Cancer through Enhancing Focal Adhesion Kinase Activation via NF-κB Signaling Pathway;Molecular Cancer Research;2020-12-09

3. Focal adhesion kinase—An emerging viable target in cancer and development of focal adhesion kinase inhibitors;Chemical Biology & Drug Design;2020-11-27

Role of Focal Adhesion Kinase in Head and Neck Squamous Cell Carcinoma and Its Therapeutic Prospect

;OncoTargets and Therapy;2020-10

5. FAK-targeted and combination therapies for the treatment of cancer: an overview of phase I and II clinical trials;Expert Opinion on Investigational Drugs;2020-03-19